This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

NovaBay Highlights Data From Phase 2 UCBE Study.

Stocks in this article: NBY

NovaBay Pharmaceuticals, Inc., an advanced clinical-stage biopharmaceutical company developing topical antimicrobial products, today released a video of its Analyst and Investor Event which was held on September 17th in New York City.

At the event, Dr. Ron Najafi, Chairman and Chief Executive Officer of NovaBay, provided an overview of the company’s goals and milestones reached. NovaBay senior management team along with the clinicians involved in the study and key opinion leaders presented the data from NovaBay’s phase 2 clinical study of auriclosene to reduce urinary catheter blockage and encrustation (UCBE) of indwelling urinary catheters.

UCBE Analyst Day Video

NovaBay Highlights Data from Phase 2 UCBE Study. Video can be viewed here. Highlighted in the video are:

  • Ron Najafi, Ph.D., Chairman and CEO, NovaBay
  • Keith R. Bley, Ph.D., Senior Vice President of Product Development, NovaBay;
  • Todd Linsenmeyer, M.D., Director of Urology at the Kessler Institute for Rehabilitative Medicine in West Orange, NJ and the principal investigator in NovaBay’s phase 2 UCBE study;
  • V. Spencer Long, M.D., Urologist at J.C. Blair Memorial Hospital in Huntingdon, PA; and;
  • Mary Wilde, Ph.D., R.N., Associate Professor of Nursing at the University of Rochester Medical Center.

Press release, patient and physician video, presentation, and video from the UCBE analyst and investor event are available on NovaBay’s website.

Due to spinal cord injuries, multiple sclerosis, strokes, or neurogenic bladder conditions, an estimated 100,000 patients in the U.S. have indwelling catheters and episodically suffer from blockage and encrustation. In these patients, catheters repeatedly become colonized with bacteria and bacterial biofilm, which may produce localized crystal deposits that may build up and block the catheter. Urinary catheter blockages pose health risks to these patients and are a contributor to medical emergencies, increased health care costs and decreased quality of life.

1 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs